BioSpace News Archive

Business

SAREUM HOLDINGS PLC FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018

Sareum Holdings plc announces its results for the year ended 30 June 2018 and provides an update of significant post-period events.

October 3, 2018
·
5 min read
Prime Hospital performs delicate spinal operation using minimally-invasive spinal surgical technology

The Spine Care Center of Prime Hospital, the UAE’s leading healthcare service provider, has successfully performed a delicate spinal operation using minimally invasive surgical technologies on an Argentinian lady suffering from low back pain.

October 3, 2018
·
2 min read
Almac Group Launches Global Analytical Services Capability

Almac Group is delighted to announce its global analytical services capabilities spanning UK, Europe and North America.

October 3, 2018
·
2 min read
Business

Kangstem Biotech selects MaSTherCell for GMP manufacturing of FURESTEM-AD(R) in Europe

Kangstem Biotech today announces the selection of MaSTherCell as its contract manufacturing partner for its European clinical trial of FURESTEM-AD(R).

October 3, 2018
·
3 min read
Genetown

Aldeyra could face an uphill battle in securing a strong position in the dry eye market, says GlobalData

Aldeyra Therapeutics is aiming to directly compete with Shire and Allergan in the dry eye syndrome market, a lucrative segment estimated to be worth $2.4bn in 2017 in the eight major markets (8MM*), according to GlobalData, a leading data and analytics company.

October 3, 2018
·
3 min read
FDA

Eisai’s Fycompa Newly Approved by U.S. FDA as Treatment for Partial-Onset Seizures in Pediatric Patients with Epilepsy

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai’s antiepileptic drug (AED) Fycompa (perampanel)

October 3, 2018
·
7 min read
Business

Scientific success leads to strong portfolio of commercial deals for UK-based microbiome company, OptiBiotix Health

In September OptiBiotix signs three more agreements

October 3, 2018
·
3 min read
BioMidwest

Empirical Bioscience’s New EB Pure Plasmid Mini-Prep Kit Offers High-Quality DNA in 30 Minutes or Less

Empirical Bioscience announced the introduction of a new EB Pure Plasmid Mini-Prep Kit today.

October 3, 2018
·
1 min read
Deals

Allogene Therapeutics Eyes IPO of up to $288 Million

Six months after officially launching and one month after securing $120 million in private financing, Allogene Therapeutics is looking to score between $272 and $288 million from an initial public offering.

October 3, 2018
·
2 min read
·
Alex Keown
Genetown

TESARO Announces Data Presentations at the SITC 2018 Annual Meeting

TESARO, Inc. today announced that data from a total of five abstracts will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting from November 7-11, 2018 in Washington, D.C.

October 3, 2018
·
3 min read